𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia

✍ Scribed by Eva Klein; Farkas Vánky; Hannah Ben-Bassat; Hava Neumann; Peter Ralph; Jesper Zeuthen; Aaron Polliack


Publisher
John Wiley and Sons
Year
1976
Tongue
French
Weight
910 KB
Volume
18
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The K562 cell line derived from a CML patient in blast crisis was examined for properties of B and T lymphocytes and cell lines. K562 lacks the B markers of immunoglobulin, Epstein‐Barr virus (EBV) genome and associated nuclear antigen, and receptors for EBV. A low proportion of cells form rosettes with sheep erythrocytes, the frequency of which is considerably increased after neuraminidase treatment. Unlike B lines but like T lines, K562 cells are lysed rapidly by C'/Fc receptor‐positive human blood leukocytes and do not stimulate MLC reactions. On the other hand, K562 lacks T antigen, high radiosensitivity and sensitivity to growth inhibition by thymidine. The cells do not contain N‐APase, an enzyme found in all lines derived from lymphoid cells and in lymphoproliferative diseases. By scanning electron microscopy, K562 cells were seen to be rounded and relatively smooth, with small numbers of short microvilli resembling undifferentiated leukemic cells. A few cells had narrow ridge‐like profiles and small ruffles similar to granulocytic leukemic cells. K562 is strongly positive for immunoglobulin Fc receptors and pinocytosis, but does not phagocytose or mediate antibody‐dependent phagocytosis or cytolysis. Among histochemical stains, K562 is positive for esterase, lipid, and acid phosphatase. There seems to be no doubt that K562 is not a B cell line. While it has some T cell properties, these are not exclusive. Some of its characteristics indicate that it is probably not lymphoid. Due to its low level of differentiation, its nature cannot be stated with certainty. On the basis of the possible presence of the cellular marker of chronic myeloid leukemia, the Ph chromosome, it may be regarded as belonging to the granulocytic series of cells.


📜 SIMILAR VOLUMES


Comparative genomic hybridization reveal
✍ Philip Rodley; Margaret McDonald; Brent Price; Richard Fright; Christine Morris 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

We used comparative genomic hybridization (CGH) to identify a number of previously undescribed chromosomal imbalances in K-562, a spontaneously transformed cell line originally derived from leukemic cells of a chronic myeloid leukemia (CML) patient in blast crisis. Noteworthy were a discrete amplifi

Chromosome analyses of lymphoid cell lin
✍ V. Najfeld; P. J. Fialkow; A. Karande; K. Nilsson; G. Klein; G. Penfold 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 620 KB

## Abstract To study chromosome complements of chronic lymphocytic leukemia cells, six Epstein‐Barr virus‐transformed lymphoid lines were established from two patients with this disease who were heterozygous for the X‐chromosome‐linked enzyme glucose‐6‐phosphate de‐hydrogenase (G6PD). Immunoglobuli

Establishment of a lymphoid cell line fr
✍ A. Karande; P. J. Fialkow; K. Nilsson; S. Povey; G. Klein; V. Najfeld; G. Penfol 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 678 KB

## Abstract Two lymphoid cell lines were established from a patient with chronic lymphocytic leukemia by infecting blood cells with Epstein‐Barr virus (EBV). Studies of morphology, glucose‐6‐phosphate dehydrogenase, malic enzyme, immunoglobulin, and chromosomes of the two lines indicated that one o

Establishment of the acute myeloid leuke
✍ Hiroya Asou; Adrian F. Gombart; Seisho Takeuchi; Hideo Tanaka; Maki Tanioka; Hir 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## Abstract A myeloid leukemia cell line designated Kasumi‐6 was established from the bone marrow cells of an individual with acute myeloid leukemia, subtype M2. Both the original leukemic cells and the Kasumi‐6 cell line harbor a hemizygous point mutation in the gene encoding the CCAAT/enhancer bi